German China India

Brazil: Farnesene Production

DSM Acquires Amyris Brasil

| Editor: Alexander Stark

DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris
DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris (Source: )

Royal DSM and Amyris announced that they have closed the transaction for the sale of Amyris Brasil to DSM and the establishment of a long-term manufacturing partnership for Amyris’s high-volume products.

Heerlen/The Netherlands — The consideration for Amyris Brasil (which owns and operates the Brotas 1 fermentation facility) and intellectual property related to farnesene (a bio-based key intermediate for many applications) is $ 58 million plus an additional value share arrangement over a three-year period amounting to $ 37.5 million (aggregate upfront consideration of $ 96 million). In addition to the consideration upfront, there is potential for a future value share in line with Amyris’ business model.

DSM Acquires Brazilian Production Facility from Amyris

Brazil: Bio-Based Intermediates

DSM Acquires Brazilian Production Facility from Amyris

11/19/2017 - Royal DSM and the industrial bioscience company Amyris have enhanced their strategic alliance through the sale of Amyris Brasil Ltda to DSM and the establishment of a long-term manufacturing partnership for Amyris’ high-volume products. read...

With the acquisition of the Brotas 1 facility, DSM adds a state-of-the-art biotechnology-based production site in Brazil to its global network, with abundant availability of sustainable raw materials (sugar cane), securing production capacity for its rich pipeline of sustainable and bio-based solutions. Having broad experience in operating large-scale fermentation plants, DSM will optimize the operational performance of the site.

Comments are being loaded ....

Leave a comment
  1. Avatar
    Avatar
    Edited by at
    Edited by at
    1. Avatar
      Avatar
      Edited by at
      Edited by at

Comments are being loaded ....

Report comment

Kommentar Freigeben

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

Freigabe entfernen

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

copyright

This article is protected by copyright. You want to use it for your own purpose? Infos can be found under www.mycontentfactory.de (ID: 45070183 / Business & Economics)